Put companies on watchlist
Eckert & Ziegler SE
ISIN: DE0005659700
WKN: 565970
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Eckert & Ziegler SE · ISIN: DE0005659700 · EQS - adhoc news (135 News)
Country: Germany · Primary market: Germany · EQS NID: 1862489
19 March 2024 07:46PM

Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024.


EQS-Ad-hoc: Eckert & Ziegler SE / Key word(s): Dividend
Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024.

19-March-2024 / 19:46 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Berlin, 19 March 2024 – The Supervisory Board and Executive Board of Eckert & Ziegler (ISIN DE0005659700, TecDAX) today decided to propose to the Annual General Meeting a reduced dividend of € 0.05 per share entitled to a dividend. The liquidity thus remaining in the company will be used to finance new high-return projects in the continuously growing market for radiopharmaceuticals. This includes, in particular, the expansion of global production capacities. The dividend reduction is also intended to ensure greater independence from external financing.

In addition to the reduced dividend, EZAG shareholders are to receive one additional Pentixapharm share for each EZAG share in the course of the planned split-off of Pentixapharm AG.

In the 2023 financial year, the Eckert & Ziegler Group increased sales by 11% to € 246.1 million. Net profit for the year amounted to € 26.3 million corresponding to earnings per share of € 1.26.

For the 2024 financial year, the Executive Board expects sales of just under € 265 million and EBIT from continuing operations before one-off effects of around € 50 million.

The detailed annual financial statements for 2023 will be published on March 22, 2024.

For enquiries please contact:
Eckert & Ziegler SE, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 



End of Inside Information

19-March-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Eckert & Ziegler SE
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-0
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX, TecDax,
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1862489

 
End of Announcement EQS News Service

1862489  19-March-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1862489&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - Eckert & Ziegler SE
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.